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Background: There is growing evidence that optimal peri-operative ﬂuid management in high-risk
surgical patients improves their post-operative outcome. Functional haemodynamic parameters such
as SVV (stroke volume variation), PPV (pulse pressure variation) and SPV (systolic pressure variation)
have been shown to be superior to CVP (central venous pressure) and DCVP in predicting ﬂuid
responsiveness. The aim of this study was to determine the accuracy and threshold values of these
dynamic parameters using the minimally invasive LiDCORapid in high-risk surgical patients.
Methods: Fluid therapy in 70 patients undergoing vascular surgery was based on parameters derived
from the LiDCORapid. All patients received TIVA (total intravenous anaesthesia) and were ventilated
with 7 ml/kg tidal volume. Haemodynamic data before and after ﬂuid boluses were recorded and
analyzed retrospectively. DSVI (stroke volume index) 10% was determined to be a positive response to
a ﬂuid challenge. The AUROCs (area under the receivereoperator curves) and conﬁdence intervals
thereof were used to assess the ability of each parameter to predict ﬂuid responsiveness.
Results: 32/43 ﬂuid challenges were positive (74.4%). The correlation coefﬁcients between baseline SVV,
PPV, and SPV with DSVI were: 0.27 (p ¼ 0.08), 0.18 (p ¼ 0.25) and 0.01 (p ¼ 0.96) whilst the AUROCs
were 0.75 (0.57e0.93), 0.67 (0.48e0.85) and 0.58 (0.35e0.81) respectively. The best cut-off for SVV using
Youden’s index was 13.5%, with J ¼ 0.48. At this level, the LRþ (positive likelihood ratio) ¼ 2.74, LR
(negative likelihood ratio) ¼ 0.34 and the DOR (diagnostic odds ratio) ¼ 8.06.
Conclusion: Only the SVV was an adequate predictor of ﬂuid responsiveness in this cohort of high risk
surgical patients. Whereas PPV and SPV may be obtained from the arterial trace, estimation of the SVV
requires a cardiac output monitor which is able to convert an arterial pressure trace into an estimation of
stroke volume.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The assessment of volume status in surgical patients can be
challenging. It is still common clinical practice to use static indices
like DCVP and DMAP (mean arterial pressure) to guide volume
status and ﬂuid therapy in high-risk surgical patients. There is,
however, an accumulation of evidence to suggest that ﬁlling pres-
sures are inadequate predictors of ﬂuid status and
responsiveness.1e3 Marik et al4 performed a systematic review ofrd Floor Cheyne Wing, King’s
44 2032993727; fax: þ44
ciates Ltd. Published by Elsevier Ltthe literature pertaining to the use of central venous pressures and
concluded that there was poor correlation between CVP and
circulating blood volume, and that CVP does not predict ﬂuid
responsiveness across a wide range of clinical conditions. Recent
interest has therefore been directed towards dynamic measures of
cardiac ﬁlling such as SVV, PPV, SPV and Ddown, and DVpeak.5e10
Numerous outcome studies favouring peri-operative ﬂuid
optimisation and goal directed therapy have been published in
recent years, suggesting that judicious ﬂuid loading and/or ino-
trope therapy targeting adequate, or even supranormal values of
cardiac index and oxygen delivery may be beneﬁcial in terms of
patient outcome.11e19 The vast majority of the studies involve pre-
and/or post-operative optimisation, but a few have tackled the
more challenging subject of intra-operative optimisation.d. All rights reserved.
Table 1
Patient demographics, clinical data and type of surgery.
Patient demographics
Age 71  11.26 years
Weight 78  17 kg
ASA 3 (median)
Clinical data Number/70 (%)
Diabetes Mellitus 36 (51.4)
Anaemia 23 (32.9)
Hypertension 33 (47.1)
Cerebrovascular disease 20 (28.6)
IHD 30 (42.9)
Renal dysfunction 11 (15.7)
ETOH/Liver dysfunction 7 (10.0)
Obesity 1 (1.4)
Smoker 10 (14.3)
Bleeding diathesis 2 (2.9)
GA problems 2 (2.9)
Cachexia 1 (1.4)
COPD 4 (5.7)
Rheumatoid arthritis 3 (4.3)
b-blocker 20 (28.6)
Diuretic 19 (27.1)
Other antihypertensive 49 (70.0)
Insulin 23 (32.9)
Oral hypoglycaemic 18 (25.7)
Antibiotic 17 (24.3)
NSAID 8 (11.4)
Aspirin 41 (58.6)
H2 Antagonist 24 (34.3)
Opiod 9 (12.9)
TCA 11 (15.7)
Anticoagulation 18 (25.7)
Inhaled Bronchodilator/steroid 3 (4.3)
Oral steroid 1 (1.4)
Surgical data
Duration 4.23  1.1 h
Fem-distal 38 (54.3%)
Fem-pop 23 (32.9)
Femoral endartectomy/patch/plasty 5 (7.1)
Femefem crossover 1 (1.4)
Ax-Bifem 2 (2.9)
Below-knee bypass 1 (1.4)
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under-resuscitationwith intravenous ﬂuids will have a detrimental
impact on their outcome.20e23 Hence, if intra-operative goal
directed therapy is to be addressed, which haemodynamic
parameters are adequate predictors of volume responsiveness?
And which of these parameters can be applied easily and reliably to
the intra-operative setting when cardiovascular indices may be
subject to rapid change? At present a major, multi-centre trial of
intra-operative optimisation is underway using the LiDCORapid
(LiDCO, Cambridge, UK).
The LiDCORapid uses the PulseCo algorithm which has
remained unchanged for the last 12 years. It is designed to give
a nominal cardiac output where the PulseCo reading is scaled
according to the patients age, weight and height (in much the same
way as the CardioQ oesophageal Doppler monitor (Deltex
Medical)) rather than an absolute value being obtained by Lithium
dilution (as in the LiDCOPlus (LiDCO, Cambridge, UK), which uses
the same algorithm) or thermodilution (as in transpulmonary
thermodilution and pulmonary artery thermodilution). It therefore
cannot be compared by BlandeAltman analysis with systems
which provide an absolute cardiac output reading. Rather, its utility
lies in its ability to follow trends in cardiac output in a time-
sensitive fashion. The LiDCORapid does allow an externally vali-
dated absolute cardiac output to be input and then the device will
give a continuous reading of absolute cardiac output. This is rarely
needed in the operating room.
If we are to be persuaded that this technology is reliable and/or
useful, then we should ask whether there is any evidence sup-
porting the ability of the SVV, PPV and SPV as measured by the
LiDCORapid to predict ﬂuid responsiveness in high-risk surgical
patients, and whether the increased cost and complexity of this
approach is justiﬁed?
2. Methods and patients
70 high risk patients (classiﬁed as ‘high risk’ according to criteria published by
Priebe, British Journal of Anaesthesia, 201124 and based on European Society of
Cardiology guidelines) undergoing major vascular surgery were identiﬁed for
retrospective analysis. Institutional review board approval was sought and
conﬁrmed. All patients underwent a standard pre-operative evaluation for ﬁtness
for anaesthesia and surgery. In every case, prior to the induction of anaesthesia,
peripheral venous and radial arterial cannulae were inserted, and BIS (bispectral
index) monitoring was established. Depth of anaesthesia was adjusted to BIS 40e60.
Minimally invasive uncalibrated cardiac output monitoring was established using
the LiDCORapid. Every patient underwent standard induction and maintenance of
anaesthesia, with propofol/remifentanil TIVA and IPPV (intermittent positive pres-
sure ventilation) of tidal volume 7 ml kg1 via a supraglottic airway.
Maintenance intravenous ﬂuid therapy (0.18% NaCl, 4% dextrose) was adminis-
tered throughout at a rate of 1.0e1.5 ml kg1 h1. Fluid boluses were of colloidal
solutions, including tetrastarch (Voluven, Fresenius, UK) and gelatin (Volplex,
Beacon Pharmaceutical, Kent, UK and Gelofusine, Braun, UK) and were administered
rapidly via syringe, the total volume being administered in 3e4 min. Fluid boluses
were given according to clinical assessment of need and the available haemody-
namic parameters. Only ﬂuid boluses given in the absence of HRV >10% heart rate
variation, brisk ongoing blood loss and of 250 ml volume were included in the
evaluation.
Haemodynamic parameters before and after ﬂuid administration were identi-
ﬁed retrospectively using LiDCOviewPro (a software package which allows contin-
uous data to be reviewed both graphically and numerically). Positive response to
a ﬂuid challenge was deﬁned as DSVI of 10%. Statistical analysis was performed
using SPSS 17.0. Prediction of ﬂuid responsiveness based on SVV, PPV and SPV was
tested by calculating the AUROC for DSVI >10%. Threshold values for these variables
were determined by calculating the values that yielded the best balance between
sensitivity and speciﬁcity using Youden’s index. Based on these thresholds, positive
and negative predictive values were calculated. Pearson correlation was calculated
between the haemodynamic parameters and DSVI.
3. Results
The average age of the cohort was 71 years, median ASA 3. Co-
morbidities were typical for a vascular surgical cohort with riskfactors for arteriopathy such as diabetes and hypertension being
particularly prevalent and evidence of the consequences of end-
organ damage such as ischaemic heart disease, cerebrovascular
disease and renal dysfunction Table 1.
Of note, nearly a quarter (24.3%) of patients had been
commenced on antibiotic therapy at the time of surgery e
reﬂecting the high incidence of suspected or proven infection in the
affected limb.
The surgery performed was predominantly e but not limited
to e femoral-distal bypass and femoral-popliteal bypass. All cases
were performed under general anaesthesia; BIS monitoring
allowed adjustment of the depth of anaesthesia e average 43 in
this series.
32/43 ﬂuid challenges were positive (74.4%). The correlation
coefﬁcients between the baseline SVV, SPV, and PPV with DSVI
were: 0.27 (p ¼ 0.08), 0.01 (p ¼ 0.96), and 0.18 (p ¼ 0.25); all non-
signiﬁcant.
The best cut-off for SVV using Youden’s index was 13.5%, with
J ¼ 0.48. The receivereoperator curves are displayed below Fig. 1.
The AUROCs were 0.75 for SVV, 0.59 for SPV and 0.67 for PPV
Table 2. Only the AUROC for SVV was statistically signiﬁcant
(p ¼ 0.014).
The positive likelihood ratio, negative likelihood ratio and
diagnostic odds ratio at SVV ¼ 13.5% (sensitivity 0.75, speciﬁcity
0.73) were LRþ ¼ 2.74, LR ¼ 0.34; DOR ¼ 8.06. At SVV¼ 10.5% the
Fig. 1. Receivereoperator curves for SVV, SPV and PPV.
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speciﬁcity 0.45) with LRþ ¼ 1.66, LR ¼ 0.21 and DOR ¼ 8.05.4. Discussion
Assessment of intravascular volume can be notoriously difﬁcult
both in the operating theatre and critical care setting. Traditionally
the CVP or DCVP has been used to optimize preload. Multiple
studies and meta-analyses have failed to demonstrate the utility of
CVP in predicting those patients whowill respond to ﬂuid therapy.4
Thus, the principle reason for its use in both theatres and the
intensive care unit is without evidential foundation. Most clinicians
will have little therapeutic dilemma if the CVP is very low, but what
if the CVP is normal, or high? The CVP may provide some limited
information about right ventricular (RV) function, valve function/
dysfunction and arrhythmias. It is not, however, a measure of
circulating blood volume. It is a static haemodynamic variable
which does not reﬂect the position of the patient on the
FrankeStarling curve.
For a patient to respond to a ﬂuid challenge they must be on the
ascending part of the FrankeStarling curve and hence have
‘recruitable’ preload. Therefore physiological parameters which
reﬂect their position on this curve tend to be better predictors of
ﬂuid responsiveness. SVV, PPV and SPV are dynamic physiologic
parameters that depend on the cyclic interaction between the heart
and lung during mechanical ventilation.25e28 Inspiration causes
a reduction in right ventricular (RV) preload and an increase in RV
afterload.29 The reduction in RV preload occurs as a result of
a reduced venous pressure gradient during inspiration as the intra-
pleural pressure rises, whilst the increase in RV afterload is due to
an increase in transpulmonary pressure.29 The result of this inter-
action is a reduction in RV stroke volume which leads to a reduced
left ventricular (LV) ﬁlling volume. This ultimately leads to
a reduced LV output two to three heart-beats later and is at
a minimum during the expiratory phase of mechanicalTable 2
AUROC for the functional haemodynamic variables SVV, SPV and PPV.
Area Std. error p 95% CI
Lower Upper
SW 0.750 0.092 0.014 0.570 0.930
SPV 0.587 0.116 0.396 0.358 0.815
PPV 0.670 0.096 0.095 0.483 0.858ventilation.29 The magnitude of these changes is greater when the
patient is on the ascending part of the FrankeStarling curve as they
have recruitable preload at this stage. Fig. 2.
Static volumetric parameters like the global end diastolic
volume index (GEDVI) and intrathoracic blood volume index
(ITBVI) as measured by the transpulmonary dilution method give
information about the actual volume status but seem to be inac-
curate at predicting ﬂuid responsiveness.4,6 Similarly, the left
ventricular end diastolic volume index (LVEDVI) as measured by
echocardiography appears not to be a good predictor of ﬂuid
responsiveness.5,30 Cardiac ﬁlling pressures and cardiac end-
diastolic dimensions have been demonstrated to be unreliable.
Continuous echocardiographic monitoring is a facility which is not
usually available during routine anaesthesia.
The passive leg raise (PLR) test has been greeted with much
enthusiasm by the critical care community, and a high AUROC is
generated by this manoeuvre. The principle is that, on raising the
legs, approximately 200e300ml of bloodwill move into the central
circulation, providing a temporary ﬂuid challenge. It should come
as little surprise, then, that a positive response to this test should
herald a positive response to an intravenous ﬂuid bolus. The PLR is
impractical, however, mid-procedure in the operating room.
It has been reported that only 50% of critically unwell patients
respond to volume expansion, compared with 74.4% in this intra-
operative study of non-cardiac surgical patients. Ours was not
a group with brisk ongoing blood loss or, indeed, a group with low
systemic vascular resistance (SVR) following induction of anaes-
thesia. A number of previous studies have been performed in
patients with clinical signs of haemodynamic instability in whom
the diagnosis of hypovolaemia has been almost certain, and in
whom there is no therapeutic dilemma. Under such circumstances,
sophisticated predictors of volume responsiveness are not required.
The strength of this study is that it was performed under clini-
cally relevant circumstances e in high-risk surgical patients, under
standard operating conditions, in whom inadequate or excessive
ﬂuid resuscitation would have been potentially detrimental. BIS
monitoring ensured appropriate depth of anaesthesia. SV and other
cardiovascular responses may be obtunded if patients are too
heavily anaesthetised. The importance of multi-modality moni-
toring in peri-operative optimisation is discussed in depth in the
International Journal of Surgery 8 (2010) 90e99.31
Parameters were chosen that can be mathematically manipu-
lated with ease under pressure e such as a DSVI 10%. Other
authors have interpretedDSVIs at thresholds anywhere between 5%
and 25% as signiﬁcant. Our choice was arbitrary, chosen for prac-
tical reasons such as ease of calculation as much as evidence base,
but one which is consistent with a number of other peri-operative
studies.32e34 From a haemodynamic perspective, one might
consider that as the summit of the Starling curve is approached, the
beneﬁt, in terms of incremental rise in stroke volume and in terms
of oxygen delivery, diminishes and the risk of detrimental effects
relating to ﬂuid overload increases. Thus, the ‘therapeutic margin’Fig. 2. The derivation of stroke volume variation (SVV).
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is recorded and the clinical beneﬁt of providing, for example, a 2%
or 5% rise in DO2I might be questionable.
In terms of detecting changes in cardiac output, one also needs
to consider the properties of the technology used.35,36 The ability of
a device to track a change in cardiac output is not the same as the
accuracy of the device. The LiDCORapid is an uncalibrated system
which uses the PulseCO algorithm. The accuracy of a calibrated
system can be compared against other calibrated cardiac output
monitoring techniques (we have not used the term ‘gold standard’
or ‘reference technique’ because each method is subject to error).
An uncalibrated system delivers a ‘nominal’ cardiac output but its
most valuable property in the context of high-risk surgery is its
ability to track a change in the cardiac output over time. Broch
et al37 compared the LiDCORapid with absolute measurement of
cardiac output by transpulmonary thermodilution (TPTD) in
patients undergoing coronary artery bypass surgery. It is unsur-
prising that they found that uncalibrated ‘nominal’ cardiac output
values were not interchangeable with values obtained by thermo-
dilution. Trends of percentage changes in cardiac index measured
by pulse power analysis and TPTD were signiﬁcantly correlated.
Systems with a short time response for signal processing
generate greater variability or ‘noise’; systems which average
readings taken over a longer period may demonstrate greater
consistency, but their clinical utility may be lost when induction of
anaesthesia or brisk blood loss may produce rapid physiological
changes. It was felt that targeting increments in SVI of 10% provided
the best balance between practicality and clinical relevance and
was of sufﬁcient magnitude to be reliably detected by the monitor.
Youden’s index determined that an SVV of 13.5% was the ideal
threshold for detecting ﬂuid responsiveness. This is perhaps most
easily visualised if one considers the dot-plot, below. Fig. 3. The
diagnostic odds ratio was virtually the same in those patients with
SVV >10% (by virtue of an increased sensitivity but reduced spec-
iﬁcity). It can be appreciated from the dot-plot that moving the
threshold down will increase the sensitivity, and reduce the spec-
iﬁcity. Cannesson38 recently coined the concept of a ‘grey zone’;
with thresholds for the haemodynamic variable above which the
patient will most likely be responsive, and belowwhich the patient
will most likely be unresponsive, with values in between having
less discriminative power. It is an important concept that as clini-
cians, we are constantly faced with diagnostic uncertainty. In any
given situation, data provided by a cardiac output monitor must beFig. 3. Dot-plot of SVV in responders (DSVI 10%) versus non-responders.correlated with clinical observation. A higher or lower SVV is not
deﬁnitive but is a haemodynamic tool which may assist in the
decision-making process.
Whereas PPV and SPV can be calculated from an arterial trace,
estimation of SVV needs a monitor such as the LiDCORapidwhich
is capable of converting the pressure waveform into a measure of
stroke volume. In this study of high risk non-cardiac surgical
patients, the SVV was an adequate predictor of ﬂuid responsive-
ness. In terms of trying to quantify the magnitude of the increase in
SVI resulting from a ﬂuid bolus, correlation was best between SVV
and DSVI (p ¼ 0.08). PPV and SPV did not adequately predict ﬂuid
responsiveness, and correlated poorly with the magnitude of
change of the SVI.
Perhaps we should not be surprised that the SVV was a better
predictor of volume responsiveness given that the derivation of
SVV ¼ SV max  SV min/(SV max þ SV min/2)? SV is derived from
the arterial pressure waveform, and relies on the PulseCO algo-
rithm. PPV, on the other hand, is based on absolute measures of
pressure PPV ¼ [(SBP  DBP)max  (SBP  DBP)min]/[(SBP  DBP)
maxþ (SBPDBP)min/2]¼ PPmaxe PPmin/(PPmaxþ PPmin/2).
The SVV and PPV were very well correlated (Pearson correlation
coefﬁcient ¼ 0.87, p < 0.01). However, the ﬁnding that SVV out-
performs PPV and SPV when LiDCO technology is used is consis-
tent with studies in obese patients undergoing bariatric surgery,39
and coronary artery bypass grafting under closed chest conditions,5
but not with pooled data using other technologies.40
It must, of course, be recognised that these measures of preload
reserve can only be used in a mechanically ventilated patient.
Moreover, these are difﬁcult concepts to comprehend, and can be
misinterpreted by the inexperienced, particularly in the presence of
cardiac arrhythmia or critical damping of the arterial waveform.
Most anaesthetists and surgeons are now aware of the impor-
tance of ﬂuid balance and oxygen ﬂux in the peri-operative period.
Despite this, the use of minimally invasive cardiac output moni-
toring devices is not ubiquitous, and a lack of consensus on how the
high-risk surgical patient should be managed has done little to
promote the cause. There appears to be a consensus that ﬂuid
therapy should be “the right amount of the right type at the right
time”, but this is complex. A patient may be ﬂuid responsive, but
this does not imply that the patient necessarily needs more
ﬂuid. Two recent publications41,42 suggest that maximising
stroke volume and administering background crystalloid at
10e12 ml/kg/h with41 or without42 dobutamine to increase oxygen
delivery actually worsens outcome. More conservative regimes
using SVV and maintenance of pre-induction oxygen delivery may
be more appropriate haemodynamic targets in elective surgical
patients and ﬂuid regimes based on presumed third space loss are
potentially rendered obsolete by technologies which allow
measurement of the response to ﬂuid therapy.
The number of ‘high risk’ patients undergoing surgical inter-
ventions is increasing as peri-operative care improves. Pre-emptive
haemodynamic monitoring coupled to protocols for the mainte-
nance of tissue perfusion has been shown to reduce mortality and
organ dysfunction.43,44 The use of cardiac output monitoring for
high risk surgery was recently recommended by the National
Institute for Clinical Excellence (NICE) in the UK.45 It is remarkable
that the uptake of intra-operative cardiac output monitoring has
not been more rapid. Whether this relates to concerns over accu-
racy in speciﬁc patient groups or when there is rapid change in the
systemic vascular resistance and hence the shape of the arterial
waveform37 in the case of pulse contour techniques is not clear. It is
the view of the authors that these tools assist rational decision-
making and provide clinical consistency for the sickest patients
and for this cohort the additional cost and complexity of minimally
invasive cardiac output monitoring may be justiﬁed.
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